Palliative chemotherapy for pancreatic adenocarcinoma: a retrospective cohort analysis of efficacy and toxicity of the FOLFIRINOX regimen focusing on the older patient

MLA

Anne Katrin Berger, et al. “Palliative Chemotherapy for Pancreatic Adenocarcinoma: A Retrospective Cohort Analysis of Efficacy and Toxicity of the FOLFIRINOX Regimen Focusing on the Older Patient.” BMC Gastroenterology, vol. 17, no. 1, Dec. 2017, pp. 1–7. EBSCOhost, https://doi.org/10.1186/s12876-017-0709-3.

APA

Anne Katrin Berger, Georg Martin Haag, Martin Ehmann, Anne Byl, Dirk Jäger, & Christoph Springfeld. (2017). Palliative chemotherapy for pancreatic adenocarcinoma: a retrospective cohort analysis of efficacy and toxicity of the FOLFIRINOX regimen focusing on the older patient. BMC Gastroenterology, 17(1), 1–7. https://doi.org/10.1186/s12876-017-0709-3

Chicago

Anne Katrin Berger, Georg Martin Haag, Martin Ehmann, Anne Byl, Dirk Jäger, and Christoph Springfeld. 2017. “Palliative Chemotherapy for Pancreatic Adenocarcinoma: A Retrospective Cohort Analysis of Efficacy and Toxicity of the FOLFIRINOX Regimen Focusing on the Older Patient.” BMC Gastroenterology 17 (1): 1–7. doi:10.1186/s12876-017-0709-3.